News and Press Releases
Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel’s RWD Sources
Datavant’s privacy-preserving record linkage technology will allow Verisense Health’s digital health data to generate richer patient insights. 6 February 2024 -- Massachusetts, US -- Verisense Health Inc, a digital health...
Category: Biotechnology
Posted: February 7, 2024
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture 6 February 2024 -- New York, US -- Medidata, a Dassault Systèmes company...
Category: Clinical Trials
Posted: February 7, 2024
argenx Announces MHRA Licensing of Subcutaneous VYVGART (efgartigimod alfa) for generalised Myasthenia Gravis
VYVGART is now licensed for both intravenous (IV) and self-administered subcutaneous (SC) use in the UK 7 February 2024 -- Gerrards Cross, UK -- argenx UK, part of argenx, a...
Category: Biotechnology
Posted: February 7, 2024
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG
Informed Genomics Limited comments on launch of national BRCA gene testing programme to identify cancer risk early
7 February 2024 -- Birmingham, UK -- NHS England have launched a genetic testing programme targeting tens of thousands of people with Jewish ancestry who are more likely to carry...
Category: Biotechnology
Posted: February 7, 2024
Unit 5, Quinton Business Park, 11 Ridgeway, Quinton, Birmingham, B32 1AF
First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase 1 first-in-human clinical trial
Developed in-house by VHIO-born spin-off company Peptomyc, OMO-103 is a mini-protein targeting the MYC oncogene which is found deregulated in most, if not all tumor types. Until recently, MYC has...
Category: Drug Discovery
Posted: February 7, 2024
Senta Brandt and Gerrick Rodrigues appointed to global leadership positions at Rentschler Biopharma
Senta Brandt promoted to global position of Head of Transformation Gerrick Rodrigues promoted to Global Head of IT 6 February 2024 – Laupheim, Germany; Milford, MA, USA; and Stevenage, UK...
Category: BioManufacturing, Biotechnology
Posted: February 6, 2024
ABB Robotics and Mettler-Toledo International Inc. join forces to accelerate global adoption of flexible lab automation
Companies will accelerate adoption of robotic lab technology, redefining the limits of robotics in laboratories to accelerate innovation and address labour shortages The collaboration seamlessly integrates ABB robots with METTLER...
Category: Logistics, Manufacturing and Packing
Posted: February 6, 2024
Contract packaging/filling company, James Alexander Corp., expands facility by 40%
Among other initiatives, space makes room for two company-built automated swabbing machines, aligning with growing demand. 5 February 2024 – Blairstown, NJ, US – James Alexander Corporation, a leading manufacturer...
Category: Logistics, Manufacturing and Packing
Posted: February 5, 2024
AES Clean Technology enhances cleanroom construction capabilities through new senior appointment
1 February 2024 -- Pennsylvania, US -- A leading provider of high-performance cleanroom facilities, AES Clean Technology, has announced the appointment of John Costalas to its senior leadership team as...
Category: Manufacturing and Packing
Posted: February 1, 2024
Greenphire Announces Acquisition of Clincierge to Enhance Clinical Trial Support Services
Addition enables sponsors to solve the number one clinical trial participant obstacle – transportation, with a single industry-leading solution 1 February 2024 -- Pennsylvania, US -- Greenphire, a leading innovator in...
Category: Clinical Trials
Posted: February 1, 2024
3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN,a leading pan-European biologics CDMO
1 February 2024 – Paris, France – Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organisations (CDMOs), announced today their combination to establish a new pan-European...
Category: BioManufacturing, Drug Discovery
Posted: February 1, 2024
Yokogawa introduces CellVoyager High-Content Analysis System CQ3000
New system enables advanced analysis of live cell cultures with high-definition, high-speed 3D imaging Expands Yokogawa’s CellVoyager range, comprising its imaging devices and analysis software, to support research applications from...
Category: BioManufacturing
Posted: February 1, 2024
Yokogawa introduces CellVoyager High-Content Analysis System CQ3000
New system enables advanced analysis of live cell cultures with high-definition, high-speed 3D imaging Expands Yokogawa’s CellVoyager range, comprising its imaging devices and analysis software, to support research applications from...
Category: Biotechnology
Posted: January 31, 2024
Kindeva Drug Delivery Launches New Analytical Services Global Business Unit
31 January 2024 -- Minnesota, US and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching...
Category: Drug Delivery
Posted: January 31, 2024
Medicines and Healthcare Products Regulatory Agencyauthorises GSK’s Omjjara (momelotinib) in Great Britainfor treating splenomegaly or symptoms in adultmyelofibrosis patients with moderate to severe anaemia
First JAK inhibitor treatment in Great Britain specifically indicated for both newly diagnosed and previously treated myelofibrosis patients with moderate to severe anaemia 31 January 2024 -- Middlesex, UK --...
Category: Pharmaceutical
Posted: January 31, 2024
